SKI Market

Indian Indices

Sensex

82,462.09 186.02
( 0.23%)

Global Indices

Nasdaq

49,510.88 315.37
(0.64%)

Dow Jones

6,968.07 57.00
(0.82%)

Hang Seng

58,650.11 1,329.02
(2.32%)

Nikkei 225

10,802.86 122.27
(1.14%)

Forex

USD-INR

90.93 0.06
(0.07%)

EUR-INR

107.10 -0.16
(-0.15%)

GBP-INR

122.70 -0.03
(-0.02%)

JPY-INR

0.58 0.00
(-0.63%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5552288

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.73

108703.05

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.19

Back

Colab Platforms consolidated net profit rises 17.39% in the December 2025 quarter

Feb 14,2026

Net profit of Colab Platforms rose 17.39% to Rs 1.08 crore in the quarter ended December 2025 as against Rs 0.92 crore during the previous quarter ended December 2024. Sales rose 95.91% to Rs 45.53 crore in the quarter ended December 2025 as against Rs 23.24 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	45.53	23.24	96
OPM %	-0.11	2.32	-
PBDT	1.09	0.93	17
PBT	1.08	0.92	17
NP	1.08	0.92	17

82,462.09 186.02 ( 0.23%)

49,510.88 315.37 (0.64%)

6,968.07 57.00 (0.82%)

58,650.11 1,329.02 (2.32%)

10,802.86 122.27 (1.14%)

90.93 0.06 (0.07%)

107.10 -0.16 (-0.15%)

122.70 -0.03 (-0.02%)

0.58 0.00 (-0.63%)